To date, transgenic mice such as APP/PS1, 3xTg-AD mice (Virgili et al., 2018), scopolamine- and D-galactose (Dgal)–induced mice (Li et al., 2016; Ali et al., 2020) are used to perform efficacy evaluation and determine the mechanism of action of certain compounds. Here, APP is linked to Alzheimer disease.